Which has stronger earnings & valuation, NGVT or ASPI?

Ingevity has higher revenue and earnings than ASP Isotopes. Ingevity is trading at a lower price-to-earnings ratio than ASP Isotopes, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ingevity $1.17B 2.24 -$167.10M -$3.55 N/A ASP Isotopes $23.85M 24.59 -$175.09M -$2.08 N/A

Is NGVT or ASPI more profitable?

Ingevity has a net margin of -10.55% compared to ASP Isotopes' net margin of -644.40%. Ingevity's return on equity of 207.82% beat ASP Isotopes' return on equity. Company Net Margins Return on Equity Return on Assets Ingevity -10.55% 207.82% 9.70% ASP Isotopes -644.40% -112.46% -53.36%

Does the media favor NGVT or ASPI?

In the previous week, ASP Isotopes had 3 more articles in the media than Ingevity. MarketBeat recorded 6 mentions for ASP Isotopes and 3 mentions for Ingevity. Ingevity's average media sentiment score of 1.11 beat ASP Isotopes' score of 0.29 indicating that Ingevity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ingevity 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive ASP Isotopes 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral

Does the media favor PCT or ASPI?

In the previous week, ASP Isotopes had 2 more articles in the media than PureCycle Technologies. MarketBeat recorded 6 mentions for ASP Isotopes and 4 mentions for PureCycle Technologies. PureCycle Technologies' average media sentiment score of 0.67 beat ASP Isotopes' score of 0.29 indicating that PureCycle Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PureCycle Technologies 1 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive ASP Isotopes 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral

Which has higher valuation and earnings, ECVT or ASPI?

Ecovyst has higher revenue and earnings than ASP Isotopes. Ecovyst is trading at a lower price-to-earnings ratio than ASP Isotopes, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ecovyst $723.50M 1.93 -$71.13M -$0.55 N/A ASP Isotopes $23.85M 24.59 -$175.09M -$2.08 N/A

Is ECVT or ASPI more profitable?

Ecovyst has a net margin of -7.71% compared to ASP Isotopes' net margin of -644.40%. Ecovyst's return on equity of 11.58% beat ASP Isotopes' return on equity. Company Net Margins Return on Equity Return on Assets Ecovyst -7.71% 11.58% 4.76% ASP Isotopes -644.40% -112.46% -53.36%

Does the media prefer ECVT or ASPI?

In the previous week, ASP Isotopes had 2 more articles in the media than Ecovyst. MarketBeat recorded 6 mentions for ASP Isotopes and 4 mentions for Ecovyst. Ecovyst's average media sentiment score of 0.72 beat ASP Isotopes' score of 0.29 indicating that Ecovyst is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ecovyst 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive ASP Isotopes 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral

Do analysts recommend ASPI or UAN?

ASP Isotopes presently has a consensus price target of $13.00, indicating a potential upside of 239.87%. Given ASP Isotopes' higher possible upside, analysts clearly believe ASP Isotopes is more favorable than CVR Partners. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ASP Isotopes 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 CVR Partners 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00

Which has preferable valuation and earnings, ASPI or UAN?

CVR Partners has higher revenue and earnings than ASP Isotopes. ASP Isotopes is trading at a lower price-to-earnings ratio than CVR Partners, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio ASP Isotopes $23.85M 24.59 -$175.09M -$2.08 N/A CVR Partners $606.04M 2.11 $98.66M $11.50 10.52

Is ASPI or UAN more profitable?

CVR Partners has a net margin of 18.89% compared to ASP Isotopes' net margin of -644.40%. CVR Partners' return on equity of 40.08% beat ASP Isotopes' return on equity. Company Net Margins Return on Equity Return on Assets ASP Isotopes -644.40% -112.46% -53.36% CVR Partners 18.89% 40.08% 12.08%

Does the media refer more to ASPI or UAN?

In the previous week, ASP Isotopes had 4 more articles in the media than CVR Partners. MarketBeat recorded 6 mentions for ASP Isotopes and 2 mentions for CVR Partners. CVR Partners' average media sentiment score of 0.37 beat ASP Isotopes' score of 0.29 indicating that CVR Partners is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ASP Isotopes 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral CVR Partners 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Is BAK or ASPI more profitable?

Braskem has a net margin of -13.72% compared to ASP Isotopes' net margin of -644.40%. Braskem's return on equity of -23.17% beat ASP Isotopes' return on equity. Company Net Margins Return on Equity Return on Assets Braskem -13.72% -23.17% 2.72% ASP Isotopes -644.40% -112.46% -53.36%

Does the media favor BAK or ASPI?

In the previous week, ASP Isotopes had 5 more articles in the media than Braskem. MarketBeat recorded 6 mentions for ASP Isotopes and 1 mentions for Braskem. Braskem's average media sentiment score of 0.87 beat ASP Isotopes' score of 0.29 indicating that Braskem is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Braskem 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive ASP Isotopes 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral

ASP Isotopes (ASPI) Competitors

$3.86 -0.02 (-0.46%)

As of 01:31 PM Eastern

Compare

ASPI vs. NGVT, PCT, ECVT, UAN, and BAK

Should you buy ASP Isotopes stock or one of its competitors? MarketBeat compares ASP Isotopes with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with ASP Isotopes include Ingevity (NGVT), PureCycle Technologies (PCT), Ecovyst (ECVT), CVR Partners (UAN), and Braskem (BAK). These companies are all part of the "chemicals" industry.

How does ASP Isotopes compare to Ingevity?

Ingevity (NYSE:NGVT) and ASP Isotopes (NASDAQ:ASPI) are both basic materials companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, risk, institutional ownership, valuation, profitability, earnings, analyst recommendations and dividends.

In the previous week, ASP Isotopes had 3 more articles in the media than Ingevity. MarketBeat recorded 6 mentions for ASP Isotopes and 3 mentions for Ingevity. Ingevity's average media sentiment score of 1.11 beat ASP Isotopes' score of 0.29 indicating that Ingevity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ingevity	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
ASP Isotopes	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

Ingevity has a beta of 1.16, indicating that its share price is 16% more volatile than the broader market. Comparatively, ASP Isotopes has a beta of 3.51, indicating that its share price is 251% more volatile than the broader market.

Ingevity presently has a consensus target price of $80.00, suggesting a potential upside of 6.35%. ASP Isotopes has a consensus target price of $13.00, suggesting a potential upside of 239.87%. Given ASP Isotopes' stronger consensus rating and higher possible upside, analysts plainly believe ASP Isotopes is more favorable than Ingevity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ingevity	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20
ASP Isotopes	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Ingevity has higher revenue and earnings than ASP Isotopes. Ingevity is trading at a lower price-to-earnings ratio than ASP Isotopes, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ingevity	$1.17B	2.24	-$167.10M	-$3.55	N/A
ASP Isotopes	$23.85M	24.59	-$175.09M	-$2.08	N/A

Ingevity has a net margin of -10.55% compared to ASP Isotopes' net margin of -644.40%. Ingevity's return on equity of 207.82% beat ASP Isotopes' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ingevity	-10.55%	207.82%	9.70%
ASP Isotopes	-644.40%	-112.46%	-53.36%

91.6% of Ingevity shares are owned by institutional investors. Comparatively, 16.8% of ASP Isotopes shares are owned by institutional investors. 0.9% of Ingevity shares are owned by insiders. Comparatively, 14.4% of ASP Isotopes shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

ASP Isotopes beats Ingevity on 8 of the 15 factors compared between the two stocks.

How does ASP Isotopes compare to PureCycle Technologies?

PureCycle Technologies (NASDAQ:PCT) and ASP Isotopes (NASDAQ:ASPI) are both small-cap chemicals companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, profitability, earnings, institutional ownership and dividends.

63.0% of PureCycle Technologies shares are owned by institutional investors. Comparatively, 16.8% of ASP Isotopes shares are owned by institutional investors. 18.8% of PureCycle Technologies shares are owned by insiders. Comparatively, 14.4% of ASP Isotopes shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, ASP Isotopes had 2 more articles in the media than PureCycle Technologies. MarketBeat recorded 6 mentions for ASP Isotopes and 4 mentions for PureCycle Technologies. PureCycle Technologies' average media sentiment score of 0.67 beat ASP Isotopes' score of 0.29 indicating that PureCycle Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PureCycle Technologies	1 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
ASP Isotopes	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

PureCycle Technologies currently has a consensus price target of $12.25, suggesting a potential upside of 102.31%. ASP Isotopes has a consensus price target of $13.00, suggesting a potential upside of 239.87%. Given ASP Isotopes' higher possible upside, analysts clearly believe ASP Isotopes is more favorable than PureCycle Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PureCycle Technologies	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
ASP Isotopes	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

PureCycle Technologies has a beta of 2.5, meaning that its share price is 150% more volatile than the broader market. Comparatively, ASP Isotopes has a beta of 3.51, meaning that its share price is 251% more volatile than the broader market.

ASP Isotopes has higher revenue and earnings than PureCycle Technologies. PureCycle Technologies is trading at a lower price-to-earnings ratio than ASP Isotopes, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PureCycle Technologies	$8.35M	131.15	-$182.57M	-$1.47	N/A
ASP Isotopes	$23.85M	24.59	-$175.09M	-$2.08	N/A

ASP Isotopes has a net margin of -644.40% compared to PureCycle Technologies' net margin of -2,062.36%. ASP Isotopes' return on equity of -112.46% beat PureCycle Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PureCycle Technologies	-2,062.36%	-393.01%	-22.56%
ASP Isotopes	-644.40%	-112.46%	-53.36%

Summary

ASP Isotopes beats PureCycle Technologies on 9 of the 17 factors compared between the two stocks.

How does ASP Isotopes compare to Ecovyst?

Ecovyst (NYSE:ECVT) and ASP Isotopes (NASDAQ:ASPI) are both small-cap basic materials companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, dividends, valuation, media sentiment, earnings, analyst recommendations and profitability.

Ecovyst has a net margin of -7.71% compared to ASP Isotopes' net margin of -644.40%. Ecovyst's return on equity of 11.58% beat ASP Isotopes' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ecovyst	-7.71%	11.58%	4.76%
ASP Isotopes	-644.40%	-112.46%	-53.36%

In the previous week, ASP Isotopes had 2 more articles in the media than Ecovyst. MarketBeat recorded 6 mentions for ASP Isotopes and 4 mentions for Ecovyst. Ecovyst's average media sentiment score of 0.72 beat ASP Isotopes' score of 0.29 indicating that Ecovyst is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ecovyst	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
ASP Isotopes	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

Ecovyst presently has a consensus target price of $13.90, suggesting a potential upside of 9.19%. ASP Isotopes has a consensus target price of $13.00, suggesting a potential upside of 239.87%. Given ASP Isotopes' higher possible upside, analysts clearly believe ASP Isotopes is more favorable than Ecovyst.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ecovyst	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.71
ASP Isotopes	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Ecovyst has a beta of 1.1, suggesting that its stock price is 10% more volatile than the broader market. Comparatively, ASP Isotopes has a beta of 3.51, suggesting that its stock price is 251% more volatile than the broader market.

86.7% of Ecovyst shares are held by institutional investors. Comparatively, 16.8% of ASP Isotopes shares are held by institutional investors. 1.8% of Ecovyst shares are held by company insiders. Comparatively, 14.4% of ASP Isotopes shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Ecovyst has higher revenue and earnings than ASP Isotopes. Ecovyst is trading at a lower price-to-earnings ratio than ASP Isotopes, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ecovyst	$723.50M	1.93	-$71.13M	-$0.55	N/A
ASP Isotopes	$23.85M	24.59	-$175.09M	-$2.08	N/A

Summary

Ecovyst beats ASP Isotopes on 11 of the 17 factors compared between the two stocks.

How does ASP Isotopes compare to CVR Partners?

ASP Isotopes (NASDAQ:ASPI) and CVR Partners (NYSE:UAN) are both small-cap basic materials companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, media sentiment, dividends, analyst recommendations, institutional ownership, valuation and profitability.

ASP Isotopes presently has a consensus price target of $13.00, indicating a potential upside of 239.87%. Given ASP Isotopes' higher possible upside, analysts clearly believe ASP Isotopes is more favorable than CVR Partners.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ASP Isotopes	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
CVR Partners	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

16.8% of ASP Isotopes shares are held by institutional investors. Comparatively, 43.8% of CVR Partners shares are held by institutional investors. 14.4% of ASP Isotopes shares are held by company insiders. Comparatively, 0.4% of CVR Partners shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

ASP Isotopes has a beta of 3.51, suggesting that its share price is 251% more volatile than the broader market. Comparatively, CVR Partners has a beta of 0.15, suggesting that its share price is 85% less volatile than the broader market.

CVR Partners has a net margin of 18.89% compared to ASP Isotopes' net margin of -644.40%. CVR Partners' return on equity of 40.08% beat ASP Isotopes' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ASP Isotopes	-644.40%	-112.46%	-53.36%
CVR Partners	18.89%	40.08%	12.08%

CVR Partners has higher revenue and earnings than ASP Isotopes. ASP Isotopes is trading at a lower price-to-earnings ratio than CVR Partners, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ASP Isotopes	$23.85M	24.59	-$175.09M	-$2.08	N/A
CVR Partners	$606.04M	2.11	$98.66M	$11.50	10.52

In the previous week, ASP Isotopes had 4 more articles in the media than CVR Partners. MarketBeat recorded 6 mentions for ASP Isotopes and 2 mentions for CVR Partners. CVR Partners' average media sentiment score of 0.37 beat ASP Isotopes' score of 0.29 indicating that CVR Partners is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ASP Isotopes	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
CVR Partners	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

CVR Partners beats ASP Isotopes on 10 of the 16 factors compared between the two stocks.

How does ASP Isotopes compare to Braskem?

Braskem (NYSE:BAK) and ASP Isotopes (NASDAQ:ASPI) are both small-cap chemicals companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, risk, dividends, valuation, analyst recommendations and media sentiment.

Braskem has a net margin of -13.72% compared to ASP Isotopes' net margin of -644.40%. Braskem's return on equity of -23.17% beat ASP Isotopes' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Braskem	-13.72%	-23.17%	2.72%
ASP Isotopes	-644.40%	-112.46%	-53.36%

Braskem has a beta of 1.61, indicating that its share price is 61% more volatile than the broader market. Comparatively, ASP Isotopes has a beta of 3.51, indicating that its share price is 251% more volatile than the broader market.

In the previous week, ASP Isotopes had 5 more articles in the media than Braskem. MarketBeat recorded 6 mentions for ASP Isotopes and 1 mentions for Braskem. Braskem's average media sentiment score of 0.87 beat ASP Isotopes' score of 0.29 indicating that Braskem is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Braskem	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
ASP Isotopes	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

16.8% of ASP Isotopes shares are held by institutional investors. 0.0% of Braskem shares are held by insiders. Comparatively, 14.4% of ASP Isotopes shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Braskem currently has a consensus price target of $3.40, suggesting a potential upside of 44.37%. ASP Isotopes has a consensus price target of $13.00, suggesting a potential upside of 239.87%. Given ASP Isotopes' stronger consensus rating and higher probable upside, analysts plainly believe ASP Isotopes is more favorable than Braskem.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Braskem	5 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.38
ASP Isotopes	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

ASP Isotopes has lower revenue, but higher earnings than Braskem. ASP Isotopes is trading at a lower price-to-earnings ratio than Braskem, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Braskem	$12.66B	0.07	-$1.77B	-$4.22	N/A
ASP Isotopes	$23.85M	24.59	-$175.09M	-$2.08	N/A

Summary

ASP Isotopes beats Braskem on 10 of the 16 factors compared between the two stocks.

Get ASP Isotopes News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ASPI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ASPI vs. The Competition

Export

Metric	ASP Isotopes	CHEM Industry	Materials Sector	NASDAQ Exchange
Market Cap	$586.41M	$12.89B	$4.45B	$12.38B
Dividend Yield	N/A	2.57%	5.04%	9.36%
P/E Ratio	-1.84	34.49	20.50	24.04
Price / Sales	24.59	1.74	5,845.18	112.77
Price / Cash	N/A	11.79	24.07	48.09
Price / Book	1.61	1.83	8.57	6.17
Net Income	-$175.09M	$171.68M	$157.08M	$331.75M
7 Day Performance	-16.67%	-0.68%	-1.30%	-1.52%
1 Month Performance	-46.73%	-4.16%	-5.84%	-1.24%
1 Year Performance	-63.54%	19.89%	35.89%	17.64%

ASP Isotopes Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ASPI ASP Isotopes	1.7978 of 5 stars	$3.86 -0.5%	$13.00 +236.6%	-63.0%	$592.08M	$23.85M	N/A	76
NGVT Ingevity	2.1624 of 5 stars	$71.47 -0.8%	$80.00 +11.9%	+65.7%	$2.51B	$1.17B	N/A	1,500	Positive News
PCT PureCycle Technologies	2.6512 of 5 stars	$6.70 -8.2%	$12.25 +82.8%	-64.2%	$1.32B	$8.35M	N/A	120
ECVT Ecovyst	3.7173 of 5 stars	$11.92 +0.2%	$13.90 +16.6%	+49.8%	$1.30B	$723.50M	N/A	880
UAN CVR Partners	1.6359 of 5 stars	$117.69 +1.2%	N/A	+34.5%	$1.23B	$606.04M	10.23	300

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ASPI) was last updated on 7/20/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

ASP Isotopes (ASPI) Competitors

ASPI vs. NGVT, PCT, ECVT, UAN, and BAK

How does ASP Isotopes compare to Ingevity?

Summary

How does ASP Isotopes compare to PureCycle Technologies?

Summary

How does ASP Isotopes compare to Ecovyst?

Summary

How does ASP Isotopes compare to CVR Partners?

Summary

How does ASP Isotopes compare to Braskem?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ASPI vs. The Competition

ASP Isotopes Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

ASP Isotopes (ASPI) Competitors

ASPI vs. NGVT, PCT, ECVT, UAN, and BAK

How does ASP Isotopes compare to Ingevity?

Does the media favor NGVT or ASPI?

Which has more volatility and risk, NGVT or ASPI?

Do analysts rate NGVT or ASPI?

Which has stronger earnings & valuation, NGVT or ASPI?

Is NGVT or ASPI more profitable?

Do institutionals & insiders have more ownership in NGVT or ASPI?

Summary

How does ASP Isotopes compare to PureCycle Technologies?

Do institutionals & insiders hold more shares of PCT or ASPI?

Does the media favor PCT or ASPI?

Do analysts recommend PCT or ASPI?

Which has more risk and volatility, PCT or ASPI?

Which has preferable valuation and earnings, PCT or ASPI?

Is PCT or ASPI more profitable?

Summary

How does ASP Isotopes compare to Ecovyst?

Is ECVT or ASPI more profitable?

Does the media prefer ECVT or ASPI?

Do analysts prefer ECVT or ASPI?

Which has more risk & volatility, ECVT or ASPI?

Do institutionals and insiders have more ownership in ECVT or ASPI?

Which has higher valuation and earnings, ECVT or ASPI?

Summary

How does ASP Isotopes compare to CVR Partners?

Do analysts recommend ASPI or UAN?

Do institutionals & insiders believe in ASPI or UAN?

Which has more risk and volatility, ASPI or UAN?

Is ASPI or UAN more profitable?

Which has preferable valuation and earnings, ASPI or UAN?

Does the media refer more to ASPI or UAN?

Summary

How does ASP Isotopes compare to Braskem?

Is BAK or ASPI more profitable?

Which has more volatility & risk, BAK or ASPI?

Does the media favor BAK or ASPI?

Do institutionals and insiders have more ownership in BAK or ASPI?

Do analysts recommend BAK or ASPI?

Which has preferable earnings and valuation, BAK or ASPI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ASPI vs. The Competition

ASP Isotopes Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools